Functional assays in human embryonic stem cell derived neural crest cells to detect neurodevelopmental toxicants

dc.contributor.authorZimmer, Bastian
dc.contributor.authorLee, G.
dc.contributor.authorKadereit, Suzanne
dc.contributor.authorStuder, Lorenz
dc.contributor.authorLeist, Marcel
dc.date.accessioned2021-01-29T12:06:39Z
dc.date.available2021-01-29T12:06:39Z
dc.date.issued2011eng
dc.description.abstractProper neural development consists of several tightly regulated processes including e.g. differentiation, neurite outgrowth and migration. The main migratory cell population during neural development, the neural crest cells (NCC), emerge from the neural tube and migrate throughout the body to give rise to multiple cell types including neural and non-neural cells. To study potentially adverse effects of different compounds on the migratory potential of neural precursors, we used human embryonic stem cells (hESC) differentiated into NCC. We were able to keep the cells in a neural crest progenitor state, which allows the expansion and freezing of the cells. Furthermore, the NCC could be differentiated into peripheral neurons and Schwann cells, which confirmed their functional potential, while marker expression indicated the expected phenotype. To study the migratory potential of these cells and the effects of compounds on the migration capacity, we used the classical scratch assay which has been used successfully in many studies. LIVE cell imaging experiments demonstrated that these cells repopulate the scratch via migration independent of cell division. We could furthermore show that compounds which inhibit actin polymerisation inhibit the migration of these cells at concentrations that do not affect general cell viability or cell division. In addition to the classical scratch assay we used actin-GFP transfected cells to investigate the effects of different compounds on the actin cytoskeleton in real time using LIVE cell imaging. We therefore believe that our human based in-vitro test system is a powerful tool to detect potential neurodevelopmental toxicants and to study their mode of action.eng
dc.description.versionpublishedeng
dc.identifier.doi10.1007/s00210-011-0617-yeng
dc.identifier.urihttps://kops.uni-konstanz.de/handle/123456789/52626
dc.language.isoengeng
dc.rightsterms-of-use
dc.rights.urihttps://rightsstatements.org/page/InC/1.0/
dc.subject.ddc570eng
dc.titleFunctional assays in human embryonic stem cell derived neural crest cells to detect neurodevelopmental toxicantseng
dc.typeJOURNAL_ARTICLEeng
dspace.entity.typePublication
kops.citation.bibtex
@article{Zimmer2011Funct-52626,
  year={2011},
  doi={10.1007/s00210-011-0617-y},
  title={Functional assays in human embryonic stem cell derived neural crest cells to detect neurodevelopmental toxicants},
  number={Suppl 1},
  volume={383},
  issn={0028-1298},
  journal={Naunyn-Schmiedeberg's Archives of Pharmacology},
  author={Zimmer, Bastian and Lee, G. and Kadereit, Suzanne and Studer, Lorenz and Leist, Marcel},
  note={Meeting Abstract}
}
kops.citation.iso690ZIMMER, Bastian, G. LEE, Suzanne KADEREIT, Lorenz STUDER, Marcel LEIST, 2011. Functional assays in human embryonic stem cell derived neural crest cells to detect neurodevelopmental toxicants. In: Naunyn-Schmiedeberg's Archives of Pharmacology. Springer. 2011, 383(Suppl 1), pp. 14. ISSN 0028-1298. eISSN 1432-1912. Available under: doi: 10.1007/s00210-011-0617-ydeu
kops.citation.iso690ZIMMER, Bastian, G. LEE, Suzanne KADEREIT, Lorenz STUDER, Marcel LEIST, 2011. Functional assays in human embryonic stem cell derived neural crest cells to detect neurodevelopmental toxicants. In: Naunyn-Schmiedeberg's Archives of Pharmacology. Springer. 2011, 383(Suppl 1), pp. 14. ISSN 0028-1298. eISSN 1432-1912. Available under: doi: 10.1007/s00210-011-0617-yeng
kops.citation.rdf
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/52626">
    <dc:contributor>Zimmer, Bastian</dc:contributor>
    <dc:creator>Lee, G.</dc:creator>
    <dc:creator>Leist, Marcel</dc:creator>
    <dcterms:abstract xml:lang="eng">Proper neural development consists of several tightly regulated processes including e.g. differentiation, neurite outgrowth and migration. The main migratory cell population during neural development, the neural crest cells (NCC), emerge from the neural tube and migrate throughout the body to give rise to multiple cell types including neural and non-neural cells. To study potentially adverse effects of different compounds on the migratory potential of neural precursors, we used human embryonic stem cells (hESC) differentiated into NCC. We were able to keep the cells in a neural crest progenitor state, which allows the expansion and freezing of the cells. Furthermore, the NCC could be differentiated into peripheral neurons and Schwann cells, which confirmed their functional potential, while marker expression indicated the expected phenotype. To study the migratory potential of these cells and the effects of compounds on the migration capacity, we used the classical scratch assay which has been used successfully in many studies. LIVE cell imaging experiments demonstrated that these cells repopulate the scratch via migration independent of cell division. We could furthermore show that compounds which inhibit actin polymerisation inhibit the migration of these cells at concentrations that do not affect general cell viability or cell division. In addition to the classical scratch assay we used actin-GFP transfected cells to investigate the effects of different compounds on the actin cytoskeleton in real time using LIVE cell imaging. We therefore believe that our human based in-vitro test system is a powerful tool to detect potential neurodevelopmental toxicants and to study their mode of action.</dcterms:abstract>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/52626"/>
    <dc:contributor>Lee, G.</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:issued>2011</dcterms:issued>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:creator>Zimmer, Bastian</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T12:06:39Z</dcterms:available>
    <dc:creator>Kadereit, Suzanne</dc:creator>
    <dc:contributor>Kadereit, Suzanne</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:language>eng</dc:language>
    <dc:contributor>Studer, Lorenz</dc:contributor>
    <dc:rights>terms-of-use</dc:rights>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T12:06:39Z</dc:date>
    <dcterms:title>Functional assays in human embryonic stem cell derived neural crest cells to detect neurodevelopmental toxicants</dcterms:title>
    <dc:contributor>Leist, Marcel</dc:contributor>
    <dc:creator>Studer, Lorenz</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
  </rdf:Description>
</rdf:RDF>
kops.description.commentMeeting Abstracteng
kops.flag.isPeerReviewedfalseeng
kops.flag.knbibliographytrue
kops.sourcefieldNaunyn-Schmiedeberg's Archives of Pharmacology. Springer. 2011, <b>383</b>(Suppl 1), pp. 14. ISSN 0028-1298. eISSN 1432-1912. Available under: doi: 10.1007/s00210-011-0617-ydeu
kops.sourcefield.plainNaunyn-Schmiedeberg's Archives of Pharmacology. Springer. 2011, 383(Suppl 1), pp. 14. ISSN 0028-1298. eISSN 1432-1912. Available under: doi: 10.1007/s00210-011-0617-ydeu
kops.sourcefield.plainNaunyn-Schmiedeberg's Archives of Pharmacology. Springer. 2011, 383(Suppl 1), pp. 14. ISSN 0028-1298. eISSN 1432-1912. Available under: doi: 10.1007/s00210-011-0617-yeng
relation.isAuthorOfPublicationa69c4500-9f37-4a0f-9cdc-3ada38d37ca5
relation.isAuthorOfPublication0db89f95-8fe3-4573-8473-10ae161a335b
relation.isAuthorOfPublicationd166cc79-683e-4b5f-b4a0-8ccdd3d02bbc
relation.isAuthorOfPublication.latestForDiscoverya69c4500-9f37-4a0f-9cdc-3ada38d37ca5
source.bibliographicInfo.fromPage14eng
source.bibliographicInfo.issueSuppl 1eng
source.bibliographicInfo.volume383eng
source.identifier.eissn1432-1912eng
source.identifier.issn0028-1298eng
source.periodicalTitleNaunyn-Schmiedeberg's Archives of Pharmacologyeng
source.publisherSpringereng

Dateien